In insulin-resistant ob/ob mice, activating PPARβ/δ through GW501516 ameliorates hyperglycemia-mediated glycolysis, and lipogenesis increases in the liver so as to reduce hepatic glucose output. This evidence concerns the gene PPARD and Hyperglycemia.